Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
Clasificación en acciones #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
Precio por acción
$1.84
Última sincronización: 2026-08-21
Capitalización bursátil
$66.03M
Cambio (1 día)
0.00%
Cambio (1 año)
-8.25%
País
ES
Comercio Pangaea Oncology, S.A. (PANG)

Categoría

Historial del precio de la acción de Pangaea Oncology, S.A. (PANG)
Precio más alto de cierre: $1.84 el 2026-08-01

Precio más bajo de cierre: $2.93 el 2017-09-01
Historial del precio de la acción de Pangaea Oncology, S.A. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -2.66%
2025 8.06%
2024 15.26%
2023 2.98%
2022 -25.56%
2021 6.89%
2020 3.56%
2019 -27.13%
2018 -12.00%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US